Loading clinical trials...
Loading clinical trials...
Intervention of Spontaneous Hyperventilation in Patients With Aneurysmal Subarachnoid Hemorrhage: the Feasibility of Drug Therapy and Its Impact on Cerebral Blood Flow
Conditions
Interventions
Remifentanil Injection [Ultiva]
Locations
1
China
ICU, Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Start Date
June 1, 2021
Primary Completion Date
December 31, 2021
Completion Date
March 31, 2022
Last Updated
June 25, 2021
NCT07160088
NCT07307508
NCT06409364
NCT04566991
NCT06855407
NCT04507178
Lead Sponsor
Capital Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions